These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35785727)

  • 21. Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.
    Mahmoudi Z; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
    APMIS; 2020 Jul; 128(7):476-483. PubMed ID: 32445596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
    Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Aghajani Z; Abdollahi S; Khalili S; Talei D; Eslam ED
    Sci Rep; 2021 Jan; 11(1):1914. PubMed ID: 33479293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Response to Conjugates of Fragments of the Type K9 Capsular Polysaccharide of Acinetobacter baumannii with Carrier Proteins.
    Rudenko N; Karatovskaya A; Zamyatina A; Shepelyakovskaya A; Semushina S; Brovko F; Shpirt A; Torgov V; Kolotyrkina N; Zinin A; Kasimova A; Perepelov A; Shneider M; Knirel Y
    Microbiol Spectr; 2022 Oct; 10(5):e0167422. PubMed ID: 35980044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acinetobacter baumannii outer membrane protein 34 elicits NLRP3 inflammasome activation via mitochondria-derived reactive oxygen species in RAW264.7 macrophages.
    An Z; Su J
    Microbes Infect; 2019; 21(3-4):143-153. PubMed ID: 30439507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
    Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
    Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
    McConnell MJ; Rumbo C; Bou G; Pachón J
    Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
    Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
    Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
    Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
    Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
    Uppuluri P; Lin L; Alqarihi A; Luo G; Youssef EG; Alkhazraji S; Yount NY; Ibrahim BA; Bolaris MA; Edwards JE; Swidergall M; Filler SG; Yeaman MR; Ibrahim AS
    PLoS Pathog; 2018 May; 14(5):e1007056. PubMed ID: 29746596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
    Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
    PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.
    McConnell MJ; Domínguez-Herrera J; Smani Y; López-Rojas R; Docobo-Pérez F; Pachón J
    Infect Immun; 2011 Jan; 79(1):518-26. PubMed ID: 20974823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
    Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
    Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic immunoprotection by Oma87 and Bap against Acinetobacter baumannii sepsis model.
    Mansouri M; Sadeghpoor M; Abdollahi M; Vafaei AJ; Jalali Nadoushan M; Rasooli I
    Int Immunopharmacol; 2023 Sep; 122():110650. PubMed ID: 37454632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.